Top Stories
Patients can practise everyday tasks made difficult by strokes and other neurological conditions, with therapists tailoring their exercises and monitoring progress remotely.
The company's AI-powered PCI Navigator planning tool prompted changes to treatment plans in 70% of cases.
The findings point to a potential new way to monitor the disease without repeated tissue biopsies.
The money will fund a pivotal trial of StimCardio's Rhyvive wearable following promising early results.
The company's virtual mental health business saw insurance-covered therapy revenue reach $32.1 million, helping offset a sharp decline in direct-to-consumer sales.
Conference News
Conavi Medical Presents Data Demonstrating Feasibility of ...
- PBGENE-HBV late-breaking oral presentation for ELIMINATE-B trial at AASLD's The Liver Meeting® 2026 on November 8; data abstract scheduled for release November 5 -- Dosed first patient with PBGENE-D...
The analysis, published simultaneously in JACC, found that moderate AS patients with at least one at-risk feature had a two-fold increase in mortality and hospitalization with heart failure compared w...
Sunnyvale, California, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Shyld AI, a Silicon Valley based AI company building autonomous physical intelligence, will demonstrate its Active AI technology at HLTH USA 20...
Nanox.AI's Investigational AVC Solution Demonstrated 98.3% Sensitivity and 96.6% Specificity in Evaluable CT Scans.Findings Highlight the Potential of AI to Identify Previously Unreported Aortic Valve...
